Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs.

Persons

Aaron Seth Kesselheim

Venue / Journal

BMJ Med

Date

Sat, 01/01/2022 - 12:00

Additional Journal Information

1(1):e000227

Authors

Mitra-Majumdar M, Powers JH, Brown BL, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/36936591